Table 1.
Variable | HCC (n = 22) n (%) | Cirrhosis (n = 22) n (%) | P-value |
---|---|---|---|
Age (years) (X ±SD) | 60.09 ±5.06 | 58.59 ±7.83 | 0.455 |
Male sex | 9 (40.9) | 14 (63.6) | 0.131 |
Splenomegaly by US | 12 (54.5) | 20 (90.9) | 0.007* |
Ascites grade by US | 0.060 | ||
None | 1 (4.5) | 7 (31.8) | |
Mild-moderate | 2 (9.1) | 2 (9.1) | |
Severe | 19 (86.4) | 13 (59.1) | |
CTP score (X ±SD) | 11.18 ±2.04 | 9.91 ±2.91 | 0.100 |
CTP class | 0.338 | ||
Class A | 0 (0.0) | 2 (9.1) | |
Class B | 9 (40.9) | 9 (40.9) | |
Class C | 13 (59.1) | 11 (50.0) | |
PV thrombosis by CT | 7 (31.8) | 0 (0.0) | 0.004* |
Number of FL by CT | – | – | |
Single | 6 (27.3) | ||
Two/three | 8 (36.4) | ||
More than three | 8 (36.4) | ||
Size of largest FL (cm) (X ±SD) | 4.43 ±2.01 | – | – |
Liver lobes involved | – | – | |
One lobe | 10 (45.5) | ||
Both lobes | 12 (54.5) | ||
LN involvement by CT | 1 (4.5) | – | – |
Extrahepatic spread | 0 (0.0) | – | – |
BCLC stage of HCC | – | – | |
Very early stage | 0 (0.0) | ||
Early stage | 7 (31.8) | ||
Intermediate stage | 2 (9.1) | ||
End-stage | 13 (59.1) |
Data are expressed as mean (X) ± standard deviation (SD) or as number (n) and percent (%)
Statistically significant at p < 0.05
HCC – hepatocellular carcinoma, CTP – Child-Turcotte-Pugh, US – ultrasound, CT – triphasic CT-scan, PV – portal vein, FL – focal lesions, LN – lymph nodes, BCLC – Barcelona Clinic Liver Cancer.